These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4939474)

  • 61. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pseudotolerance observed in adult mice with repeated injections of rat erythrocytes].
    Solov'ev VV; Fontalin LN; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1972 Aug; 73(8):55-8. PubMed ID: 4673782
    [No Abstract]   [Full Text] [Related]  

  • 65. Cyclophosphamide-induced tolerance in fully allogeneic heart transplantation in mice.
    Matsuura A; Katsuno M; Suzuki Y; Ito T; Yasuura K; Abe T; Yoshikai Y
    Cell Immunol; 1994 May; 155(2):501-7. PubMed ID: 8181080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Skin and transplant reaction in mice to the introduction of lymphoid cells of a donor sensitized with inducing microbial antigens].
    Ogurtsov RP; Zubzhitskiĭ IuN
    Vestn Akad Med Nauk SSSR; 1971; 26(1):22-5. PubMed ID: 4928208
    [No Abstract]   [Full Text] [Related]  

  • 67. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 68. [Quantitative aspects of modern radiation immunology and problem of the action of radiation on intercellular cooperative processes].
    Petrov RV; Koval'chuk LV; Cheredeev AN
    Radiobiologiia; 1971; 11(4):483-94. PubMed ID: 4939572
    [No Abstract]   [Full Text] [Related]  

  • 69. Immunosuppression by chemical agents.
    Bach JF
    Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894
    [No Abstract]   [Full Text] [Related]  

  • 70. Antibody formation by transferred peritoneal cells and spleen cells of mice. II. Transfer of peritoneal cells from immunized irradiated donors to syngeneic recipients with and without antigen.
    Kornfeld L; Weyzen WW
    J Reticuloendothel Soc; 1971 Feb; 9(2):162-73. PubMed ID: 5170586
    [No Abstract]   [Full Text] [Related]  

  • 71. [Effect of the antinoeplastic antibiotic 1719 from the group of diazo compounds on the immunological reactivity of the organism].
    Shapovalova SP
    Antibiotiki; 1973 Jul; 18(7):635-9. PubMed ID: 4589935
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Scand J Immunol; 2009 Nov; 70(5):423-30. PubMed ID: 19874546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunosuppressive properties of yeast extract.
    Wojskowicz J; Błaszczyk B
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):27-32. PubMed ID: 6351797
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [In vivo culture studies on the effect of L-asparaginase on various phases of humoral antibody production].
    Hoppe I; Jahn E
    Arzneimittelforschung; 1972 Jun; 22(6):985-9. PubMed ID: 5068361
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunosuppression by leukemia viruses. VII. Stimulatory effects of Friend leukemia virus on pre-existing antibody-forming cells to sheep erythrocytes and Escherichia coli in non-immunized mice.
    Hirano S; Friedman H; Ceglowski WS
    J Immunol; 1971 Nov; 107(5):1400-9. PubMed ID: 4940622
    [No Abstract]   [Full Text] [Related]  

  • 76. Procarbazine as an immunosuppressant in animals.
    Stewart PB; Bell R
    J Immunol; 1970 Nov; 105(5):1271-7. PubMed ID: 4922984
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunosuppressive activity of the oncogenic purine derivative 3-hydroxyxanthine.
    Teller MN; Smullyan I
    Isr J Med Sci; 1971 Jan; 7(1):66-71. PubMed ID: 5545771
    [No Abstract]   [Full Text] [Related]  

  • 78. Influence of immunosuppressive drugs on replication of Col MM virus and productive of interferon in vivo.
    Golubska B; Szalaty H
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):445-56. PubMed ID: 4371712
    [No Abstract]   [Full Text] [Related]  

  • 79. Long term administration of cyclophosphamide into MRL/1 mice. II. The effects on the isotype of anti-DNA antibodies and immunoglobulin secreting cells in the spleen.
    Shiraki M; Fujiwara M
    Clin Exp Immunol; 1984 Mar; 55(3):519-24. PubMed ID: 6608425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The immunoregulatory roles of natural killer T cells in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Shimizu I; Kajiwara T; Onzuka T; Okano S; Yasunami Y; Yoshikai Y; Nomoto K; Tominaga R
    Transplantation; 2007 Dec; 84(12):1686-95. PubMed ID: 18165782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.